TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Campus Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
22,855
|
18,912
|
15,733 |
| Financial expenses |
57
|
121
|
107 |
| Earnings before taxes |
2,537
|
-459
|
-851 |
| EBITDA |
3,951
|
2,021
|
1,566 |
| Total assets |
9,768
|
12,012
|
10,730 |
| Current assets |
9,206
|
9,706
|
6,395 |
| Current liabilities |
5,520
|
6,283
|
4,598 |
| Equity capital |
4,242
|
5,638
|
6,132 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
43
|
38
|
30 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.4%
|
46.9%
|
57.1% |
| Turnover per employee |
532
|
498
|
524 |
| Profit as a percentage of turnover |
11.1%
|
-2.4%
|
-5.4% |
| Return on assets (ROA) |
26.6%
|
-2.8%
|
-6.9% |
| Current ratio |
166.8%
|
154.5%
|
139.1% |
| Return on equity (ROE) |
59.8%
|
-8.1%
|
-13.9% |
| Change turnover |
4,586
|
3,134
|
604 |
| Change turnover % |
25%
|
20%
|
4% |
| Chg. No. of employees |
5
|
8
|
3 |
| Chg. No. of employees % |
13%
|
27%
|
11% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.